Tilray Brands free cash flow TLRY
Cash from operations less capital spending, by quarter and over the last twelve months, from 2017.
- Last 12 months, to May 31, 2025
- −$127.5M
- Latest quarter, Q4 FY25
- −$19.1M
- −191% on a year earlier
- Fiscal year 2025
- −$127.5M
Tilray Brands' free cash flow was −$127.5M over the twelve months to May 31, 2025.
In its latest quarter, Q4 FY25, it was −$19.1M, down 191% on the same quarter a year before.
Free cash flow over time
Fiscal year by fiscal year
| Fiscal year | Free cash flow | Change |
|---|---|---|
| FY2025 | −$127.5M | n/a |
| FY2024 | −$60.2M | n/a |
| FY2023 | −$12.9M | n/a |
| FY2022 | −$211.3M | n/a |
| FY2021 | n/a | n/a |
| FY2020 | n/a | n/a |
| FY2019 | −$331.8M | n/a |
| FY2018 | −$96.4M | n/a |
| FY2017 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | Free cash flow | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q4 FY25 | −$19.1M | −191% | −$127.5M | |
| Q3 FY25 | −$20.2M | n/a | −$87.4M | |
| Q2 FY25 | −$46.2M | n/a | −$92.1M | |
| Q1 FY25 | −$42M | n/a | −$82.2M | |
| Q4 FY24 | $21M | −33% | −$60.2M | |
| Q3 FY24 | −$24.9M | n/a | −$50M | |
| Q2 FY24 | −$36.3M | −247% | −$44.6M | |
| Q1 FY24 | −$20M | n/a | $16.4M | |
| Q4 FY23 | $31.2M | n/a | −$12.9M | |
| Q3 FY23 | −$19.5M | n/a | −$70.2M | |
| Q2 FY23 | $24.7M | n/a | −$101.7M | |
| Q1 FY23 | −$49.3M | n/a | −$151.1M |
Against its peers
Companies in Chemicals nearest Tilray Brands' size, closest first, today.
| Company | Free cash flow yield |
|---|---|
| TLRYTilray Brands | n/m |
| FTKFlotek Industries | −0.5% |
| NAGENiagen Bioscience | n/m |
| CRONCronos | 4.0% |
| FTLFFitlife Brands | 12.8% |
| ROGRogers | 3.7% |
| NGVTIngevity | 6.5% |
| IOSPInnospec | 2.9% |
| FULFuller H B | 3.7% |
| WDFCWD 40 | 2.8% |
| AVNTAvient | 5.1% |
| Peer median | 3.7% |
What the free cash flow tells you
Cash from operations minus capital spending. The cash the company could hand back or reinvest.
Seasonal and lumpy quarter to quarter. The TTM view is the one to trust.
More on Tilray Brands
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.